A Study to Evaluate the Effects of a Single and Multiple Oral Doses of GLPG3121 in Adult, Healthy, Male Subjects

NCT03899909 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

31

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: GLPG3121 SAD
DRUG: Placebo SAD
DRUG: GLPG3121 MAD
DRUG: Placebo MAD

Sponsor

Lakefront Biotherapeutics NV